Assessment of Potential Interactions Between GBR 12909 and Cocaine - 1
Recruitment status was Active, not recruiting
The purpose of this study is to assess potential interactions between intravenous (IV) cocaine and 3 doses of GBR 12909.
|Study Design:||Primary Purpose: Treatment|
|Official Title:||Study of Interactions Between GBR 12909 and Cocaine|
- Heart rate
|Study Start Date:||June 2004|
|Estimated Study Completion Date:||June 2005|
This is Phase 1, double-blind, placebo-controlled human laboratory clinical pharmacology study that will assess the potential interactions between IV cocaine and 3 escalating oral doses of GBR 12909. The primary objective is to determine safety of GBR 12909 administration and if there are significant interactions between GBR 12909 treatment concurrent with IV cocaine infusions.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00100113
|United States, Texas|
|U of Texas Medical Branch Galveston|
|Galveston, Texas, United States, 77555 1031|
|Principal Investigator:||Kathryn Cunningham, Ph.D.||University of Texas Medical Branch - Galveston|